Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Financial Results
    • Siemens net profit up...

    Siemens net profit up 18 percent at Rs 219 crore in March quarter

    Written by Ruby Khatun Khatun Published On 2018-05-06T10:00:01+05:30  |  Updated On 6 May 2018 10:00 AM IST
    Siemens net profit up 18 percent at Rs 219 crore in March quarter

    New Delhi: Siemens posted 18 percent jump in its standalone net profit to Rs 219.7 crore in the quarter ended March 31, mainly on account of higher revenues.


    The company had reported Rs 186.2 crore standalone net profit in the March quarter last year, Siemens Ltd said in a statement.


    The company follows the financial year from October to September.


    "For the second quarter of Financial Year 2018, ended March 31, 2018, Siemens Ltd registered a revenue of Rs 3,163.1 crore which amounts to a 10.6 percent increase in revenue (excluding from the revenue for the corresponding quarter of the previous year the impact of Excise Duty) over the same quarter in the preceding year," it said.




    The company said that the new orders for the period stood at Rs 2,923.6 crore. There was an increase in orders of 22 percent in its base business (orders of value less than Rs 100 crore) for the second quarter of the financial year 2018 and 21 percent for the first half of 2017-18.


    Large orders won during the second quarter of the financial year 2017 included an order from Power Grid Corporation for the Pugalur-Thrissur high-voltage direct current (HVDC) transmission system, it added.


    "While our base business is growing satisfactorily, we do not see a pipeline of large and mega projects yet. Government tendering of large projects in the Energy business (Generation, Transmission & Distribution) has slowed down, though we do see private sector Capex beginning to expand.


    Our focus continues on our Digitalisation initiatives and on ensuring operational excellence, both of which are reflected in our results," Siemens MD and CEO Sunil Mathur said in the statement.

    Financial resultsgovernmentMarch-quarternet profitrevenuesSiemensSunil Mathur
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok